SELLAS Life Sciences Group, Inc. (SLS) Operating income 2016–2025
SELLAS Life Sciences Group, Inc. (SLS) annual operating income history from SEC filings — each fiscal year as reported.
-$28.3MFY2025 · since FY2016: -$16.0M → -$28.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$28.3M | +10.3% |
| FY2024 | -$31.5M | +16.8% |
| FY2023 | -$37.9M | +9.7% |
| FY2022 | -$42.0M | -65.8% |
| FY2021 | -$25.3M | -48.9% |
| FY2020 | -$17.0M | +15.3% |
| FY2019 | -$20.0M | — |
| FY2017 | -$23.0M | -44.1% |
| FY2016 | -$16.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice